Skip to main content

Table 2 Maternal outcomes in first-time pregnancies with a history of at least two sarcoidosis-coded health care visits and general population comparator pregnancies in Sweden, crude and adjusted risk ratios with 95% confidence intervals, 2002–2013

From: Maternal and infant outcomes in sarcoidosis pregnancy: a Swedish population-based cohort study of first births

 

Sarcoidosis

pregnancies

(n = 182)

n (%)

General population

pregnancies

(n = 6630)

n (%)

Crude

Risk Ratio

(95% CI)

Adjusted

Risk Ratioa

(95% CI)

Antepartum

 Gestational diabetes

< 5

71 (1.1)

NA

NA

 Gestational hypertension

6 (3.3)

207 (3.1)

1.1 (0.5, 2.3)

0.9 (0.4, 2.1)

 Preeclampsia/eclampsia

16 (8.8)

354 (5.3)

1.6 (1.0, 2.7)

1.6 (1.1, 2.6)

 Stillbirth

< 5

26 (0.4)

NA

NA

Delivery

 Cesarean delivery

54 (29.7)

1414 (21.3)

1.4 (1.1, 1.7)

1.3 (1.0, 1.6)

 Emergency

36 (19.8)

912 (13.8)

1.5 (1.1, 2.0)

1.4 (1.0, 1.9)

 Elective

18 (9.9)

502 (7.6)

1.4 (0.9, 2.2)

1.3 (0.8, 2.0)

 Operative-vaginal

25 (13.7)

923 (13.9)

1.1 (0.8, 1.6)

1.1 (0.7, 1.5)

 Postpartum hemorrhage

13 (7.1)

404 (6.1)

1.2 (0.7, 2.0)

1.1 (0.6, 1.9)

 Placental abruption

0 (0)

21 (0.3)

NA

NA

Antepartum and postpartum (within 3 months)

 Infection

< 5

207 (3.1)

NA

NA

 Venous thromboembolism

0 (0)

17 (0.2)

NA

NA

 Cardiac arrest

0 (0)

0 (0)

NA

NA

 Maternal death

0 (0)

0 (0)

NA

NA

  1. NA Not assessed if less than 5 cases to minimize identifiability of individuals
  2. aAdjusted for maternal age, calendar year, and educational level. If there were ≤ 10 events in the exposed or unexposed groups, models were only adjusted for age and year. Preeclampsia/eclampsia was further adjusted for body mass index and smoking status